| Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy M Hu, Y Wang, L Xu, S An, Y Tang, X Zhou, J Li, R Liu, L Huang Nature communications 10 (1), 2993, 2019 | 100 | 2019 |
| mRNA delivery of a bispecific single‐domain antibody to polarize tumor‐associated macrophages and synergize immunotherapy against liver malignancies Y Wang, K Tiruthani, S Li, M Hu, G Zhong, Y Tang, S Roy, L Zhang, J Tan, ... Advanced Materials 33 (23), 2007603, 2021 | 83 | 2021 |
| Modeling pharmacokinetics and pharmacodynamics of therapeutic antibodies: progress, challenges, and future directions Y Tang, Y Cao Pharmaceutics 13 (3), 422, 2021 | 22 | 2021 |
| A bioluminescence resonance energy transfer-based approach for determining antibody-receptor occupancy in vivo Y Tang, K Parag-Sharma, AL Amelio, Y Cao Iscience 15, 439-451, 2019 | 13 | 2019 |
| Modeling the dynamics of antibody–target binding in living tumors Y Tang, Y Cao Scientific Reports 10 (1), 16764, 2020 | 11 | 2020 |
| Which factors matter the most? Revisiting and dissecting antibody therapeutic doses Y Tang, X Li, Y Cao Drug discovery today 26 (8), 1980-1990, 2021 | 4 | 2021 |
| A BIOLUMINESCENCE RESONANCE ENERGY TRANSFER (BRET)-BASED APPROACH FOR DETERMINING ANTIBODY-RECEPTOR OCCUPANCY IN VIVO. Y Tang, Y Cao, K Parag-Sharma, A Amelio CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S29-S29, 2020 | | 2020 |
